Do you want to read an article? Please log in or register.
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
Therap Adv Gastroenterol.
Grob L, Bluemel S, Biedermann L, Fournier N, Rossel JB, Vavricka SR, Zeitz J, Rogler G, Stallmach A, Scharl M
doi: 10.1177/1756284819895217.
COMMENTED
Inflammatory Bowel Disease
Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort
★ 1
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
United European Gastroenterol J
Greuter T, Porchet F, Braga-Neto MB, Rossel JB, Biedermann L, Schreiner P, Scharl M, Schoepfer AM, Safroneeva E, Straumann A, Rogler G, Vavricka SR
doi: 10.1177/2050640620954556
RECOMMENDED
Inflammatory Bowel Disease
Predicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol.
Beaugerie L, Rahier JF, Kirchgesner J
doi: 10.1016/j.cgh.2020.02.009.
Inflammatory Bowel Disease
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study
Am J Gastroenterol.
Scharl S, Barthel C, Rossel JB, Biedermann L, Misselwitz B, Schoepfer AM, Straumann A, Vavricka SR, Rogler G, Scharl M, Greuter T
doi: 10.1038/s41395-018-0360-9.
Inflammatory Bowel Disease
Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort
Scand J Gastroenterol.
Buer LCT, Moum BA, Cvancarova M, Warren DJ, Bolstad N, Medhus AW, Høivik ML
doi: 10.1080/00365521.
Inflammatory Bowel Disease
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort
Inflamm Bowel Dis.
Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M; Swiss IBD Cohort Study Group.
doi: 10.1093/ibd/izy054.
Inflammatory Bowel Disease
A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy
Inflamm Bowel Dis.
Yao J, Jiang X, You JHS
doi: 10.1093/ibd/izaa073.
Inflammatory Bowel Disease
Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland
Eur J Gastroenterol Hepatol.
Guilcher K, Fournier N, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study
doi: 10.1097/
RECOMMENDED
Inflammatory Bowel Disease
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort - an Epi-IBD study
doi: 10.1111/jgh.14563.